Xoma | XOMA - Cash And Equivalent

Stock Price
41.75
Daily Change
-0.25 -0.60%
Monthly
5.40%
Yearly
54.69%
Q2 Forecast
41.02

Xoma reported $143.9M in Cash and Equivalent for its fiscal quarter ending in June of 2024.





Cash And Equivalent Change Date
AbbVie USD 9.39B 4.16B Mar/2026
Agenus USD 35M 32M Mar/2026
Agios Pharmaceuticals USD 113.6M 24.47M Mar/2026
Ardelyx USD 31.21M 36.79M Mar/2026
aTyr Pharma USD 10.01M 735K Mar/2026
BioMarin Pharmaceutical USD 2.22B 910.76M Mar/2026
Celldex Therapeutics USD 35.73M 6.86M Mar/2026
Curis USD 10.14M 10.14M Jun/2025
Eli Lilly USD 5.28B 1.99B Mar/2026
Emergent BioSolutions USD 111.7M 23.9M Dec/2023
Incyte USD 4.02B 435.22M Mar/2026
MacroGenics USD 66.52M 9.3M Mar/2026
Novartis USD 6.88B 4.56B Mar/2026
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.7B 561M Mar/2026
Prothena USD 329.46M 21.93M Mar/2026
Regeneron Pharmaceuticals USD 2.96B 15.9B Mar/2026
Xoma USD 143.9M 7.68M Jun/2024